Compare PRE & SOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRE | SOR |
|---|---|---|
| Founded | 2014 | N/A |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Investment Managers |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 369.7M | 391.5M |
| IPO Year | N/A | 1995 |
| Metric | PRE | SOR |
|---|---|---|
| Price | $21.77 | $46.35 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $30.50 | N/A |
| AVG Volume (30 Days) | ★ 276.3K | 11.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $105.52 | N/A |
| Revenue Next Year | $58.16 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.09 | $38.66 |
| 52 Week High | $22.86 | $50.41 |
| Indicator | PRE | SOR |
|---|---|---|
| Relative Strength Index (RSI) | 63.51 | 49.09 |
| Support Level | $12.35 | $46.98 |
| Resistance Level | $22.86 | $50.05 |
| Average True Range (ATR) | 1.61 | 1.18 |
| MACD | 0.52 | -0.08 |
| Stochastic Oscillator | 88.56 | 43.29 |
Prenetics Global Ltd is a health sciences company dedicated to advancing consumer health. The consumer initiative is led by IM8, one of the world's fastest-growing supplement brands; Europa, one of the sports distribution companies in the USA; and CircleDNA, a direct-to-consumer DNA testing company. As the first consumer healthcare company to establish a Bitcoin treasury with its initial approximately $20 million Bitcoin purchase and board-approved comprehensive Bitcoin plan of action, Prenetics is pioneering the intersection of healthcare innovation and digital asset adoption.
Source Capital Inc is a diversified, closed-end management investment company. The investment objective of the company is to seek maximum total return for Common shareholders from both capital appreciation and investment income to the extent consistent with the protection of invested capital.